In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mitsubishi Tanabe Pharma Corporation

http://www.mt-pharma.co.jp/e/index.php

Latest From Mitsubishi Tanabe Pharma Corporation

Dr Reddy’s Gears For Generic Revlimid Run In US, Quarterly ‘Blips’ Aside

Quarterly ups and down notwithstanding, Dr Reddy’s signals continuing US launch momentum, with its generic Revlimid, for which the Indian firm claims exclusivity for two strengths, set to hit the market next month. “Low competition” assets, especially injectables, also continue to be on the deal-making radar in the US.

Sales & Earnings Strategy

Dr Reddy’s Gears For Generic Revlimid Run In US, Quarterly ‘Blips’ Aside

Quarterly ups and down notwithstanding, Dr Reddy’s signals continuing US launch momentum, with its generic Revlimid, for which the Indian firm claims exclusivity for two strengths, set to hit the market next month. “Low competition” assets, especially injectables, also continue to be on the deal-making radar in the US.

Commercial India

Psychedelics Pipeline Overview: R&D Blossoms But No Panacea Among Candidates

While the psychedelic approach to mental health has recently achieved some clinical and regulatory validation, executives in the space warn the drugs cannot cure all and barriers to market remain.

Neurology Innovation

ALS Drugs: A Long History Of Regulatory Twists At US FDA

The US FDA is set for two high-profile advisory committee meetings on potential ALS treatments before the end of 2022. Whatever the outcome, they will fit a pattern: when it comes to ALS treatments, there is very little about the regulatory process that feels routine.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
    • OTC, Consumer
    • Vaccines
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • BIXEN Corporation
    • Medicago Inc.
    • Mitsubishi Tanabe Pharma America, Inc. (MTPA)
    • Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA)
    • Mitsubishi Tanabe Pharma Singapore Pte. Ltd.
    • NeuroDerm, Ltd. (NDRM)
    • PT Mitsubishi Tanabe Pharma Indonesia
    • Mitsubishi Tanabe Pharma (Thailand)
    • MT Pharma Singapore PTE. Ltd.
    • Tai Tien Pharmaceuticals Co., Ltd.
    • Tanabe Research Laboratories U.S.A.
UsernamePublicRestriction

Register